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Bovine papillomavirus type 1 (BPV-1) requires viral proteins E1 and E2 for efficient DNA replication in host
cells. E1 functions at the BPV origin as an ATP-dependent helicase during replication initiation. Previously,
we used alanine mutagenesis to identify two hydrophilic regions of the E1 DNA binding domain (E1DBD), HR1
(E1179–191) and HR3 (E1241–252), which are critical for sequence-specific recognition of the papillomavirus
origin. Based on sequence and structure, these regions are similar in spacing and location to DNA binding
regions A and B2 of T antigen, the DNA replication initiator of simian virus 40 (SV40). HR1 and A are both
part of extended loops which are supported by residues from the HR3 and B2 -helices. Both elements contain
basic residues which may contact DNA, although lack of cocrystal structures for both E1 and T antigen make
this uncertain. To better understand how E1 interacts with origin DNA, we used random mutagenesis and a
yeast one-hybrid screen to select mutations of the E1DBD which disrupt sequence-specific DNA interactions.
From the screen we selected seven single point mutants and one double point mutant (F175S, N184Y/K288R,
D185G, V193M, F237L, K241E, R243K, and V246D) for in vitro analysis. All mutants tested in electrophoretic
mobility shift assays displayed reduced sequence-specific DNA binding compared to the wild-type E1DBD.
Mutants D185G, F237L, and R243K were rescued in vitro for DNA binding by the replication enhancer protein
E2. We also tested the eight mutations in full-length E1 for the ability to support DNA replication in Chinese
hamster ovary cells. Only mutants D185G, F237L, and R243K supported significant DNA replication in vivo
which highlights the importance of E1DBD-E2 interactions for papillomavirus DNA replication. Based on the
specific point mutations examined, we also assigned putative roles to individual residues in DNA binding.
Finally, we discuss sequence and spacing similarities between E1 HR1 and HR3 and short regions of two other
DNA tumor virus origin-binding proteins, SV40 T antigen and Epstein-Barr virus nuclear antigen 1 (EBNA1).
We propose that all three proteins use a similar DNA recognition mechanism consisting of a loop structure
which makes base-specific contacts (HR1) and a helix which primarily contacts the DNA backbone (HR3).
Papillomaviruses are members of the papovavirus family and
comprise both human and animal strains. In addition to caus-
ing common cutaneous warts, papillomaviruses can induce var-
ious skin and mucosal lesions (35, 36, 39). Some of these
lesions may progress to malignant carcinomas, depending on
the particular viral strain involved as well as environmental
factors. Malignancies which are highly associated with papillo-
mavirus infection include laryngeal, cervical, and other ano-
genital cancers, and it is noteworthy that human papillomavi-
rus (HPV) types 16, 18, 31, 33, and 45 pose an especially high
risk for females, as they are estimated to be present in at least
90% of cervical cancers (17, 27).
Bovine papillomavirus (BPV) has been used as a model for
studying the biology of papillomavirus replication, particularly
the DNA replication components. Upon entry of a host cell by
wounding or abrasion, BPV replicates its small 8-kb genome to
a multicopy episome which is maintained at steady-state levels
of up to several hundred copies per cell (14). After a steady-
state level of replication has been achieved, the viral DNA then
replicates approximately once during each host cell cycle and is
likely regulated by cell cycle controls (8, 18, 21). In order to
initiate viral DNA replication, the E1 protein forms a multi-
meric complex with the E2 protein, the viral origin of replica-
tion, and several host cell factors (2, 6, 8, 13, 15, 26, 28, 33).
The minimal BPV origin of replication is approximately 60 bp
in length and contains, in order from 5 to 3, a 23-bp AT-rich
element, an 18-bp imperfect palindrome which serves as an E1
binding site, and a 12-bp palindromic E2 binding site (20).
E1 functions as the initiator of papillomavirus DNA repli-
cation in vivo and plays several roles in this capacity. It is a
multifunctional 68-kDa phosphoprotein which cooperates with
the E2 protein to bind sequence-specifically to its cognate E1
binding element in the viral origin, facilitates origin DNA
unwinding by acting as an ATP-dependent helicase, recruits
the host cell DNA polymerase -primase complex, which then
begins de novo DNA synthesis, and interacts with regulatory
host cell factors such as cyclin E (8, 18, 23, 28, 32, 38). In
addition, the phosphorylation state of E1 has been suggested
as a regulatory device and link to the cell cycle control appa-
ratus, while sumoylation is required for nuclear localization (8,
18, 19, 21, 24, 25, 39).
How initiation proteins such as E1 recognize and interact
with specific origin sequences is a fundamental question in
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DNA replication. We previously demonstrated that an isolated
E1 polypeptide, E1121–311, retained specific origin recognition
capacity similar to full-length E1 (16). The origin recognition
activity of E1121–311 indicated that the double-stranded DNA
binding function of E1 resides in an independent domain that
could be investigated in the absence of other E1 sequences.
The precise demarcation of this functional domain has not yet
been established, but the N-terminal boundary must lie near
residue 160, as both E1159–303 and E1162–422 possess origin-
binding activity in vitro while E1162–308 does not (6, 10, 26).
Using alanine mutagenesis of E1121–311 we identified two
short hydrophilic regions, HR1 and HR3, that are critical for
origin binding (12). These results were consistent with a pre-
vious mutational study by Thorner et al. that identified DNA-
binding-negative mutants of E1 mapping to these same regions
(34). By comparison with simian virus 40 (SV40) T antigen, we
suggested that HR1 and HR3 were likely juxtaposed to form
the DNA interaction surface of the E1 DNA binding domain
(E1DBD). The subsequently determined crystal structure for
this region confirmed this prediction and revealed that HR1
was located in a structured loop region positioned adjacent to
-helix 4, which corresponds to HR3 (Fig. 1) (10). In addition,
the crystal structure revealed an overall conformational simi-
larity between the E1DBD and the T antigen DBD.
To further define critical residues for E1DBD function, we
used a random mutagenesis procedure and an in vivo yeast
one-hybrid screen to identify nonbinding mutants. The roles of
individual residues in E1-DNA interaction are discussed, and
sequence similarities between E1, T antigen, and EBNA1 are
presented.
MATERIALS AND METHODS
E1DBD mutant library construction. The yeast expression construct
pGAD424-E1DBD containing E1121–311 has been described previously (12).
Primers 5GAD424 (5-CCACTACAATGGATGATGTA-3) and 3GAD424
(5-TGCACAGTTGAAGTGAACTTG-3) were used to PCR amplify the
E1DBD region in the presence of the nucleotide analog dITP. A 50-l reaction
contained 10 mM Tris-HCl (pH 9.0) at 25°C, 50 mM KCl, 0.1% Triton X-100, 5
mM MgCl2, 200 M dCTP, 200 M dGTP, 200 M dTTP, 20 M dATP, 200
M dITP (Sigma), 50 ng of template pGAD424-E1DBD, 25 pmol of primer
5GAD424, 25 pmol of primer 3GAD424, and 1.25 U of Taq polymerase
(Promega). The reaction was run in an MJR PTC-200 thermocycler and used an
initial denaturation at 94°C for 1 min followed by 30 cycles of 94°C for 15 s, 55°C
for 30 s, and 72°C for 1 min. The single PCR product was purified using a
Qiaquick gel extraction kit (Qiagen) and quantified by UV spectroscopy.
A second PCR was run under standard conditions to generate products lacking
dITP. The 50-l reaction contained 10 mM Tris-HCl (pH 9.0) at 25°C, 50 mM
KCl, 0.1% Triton X-100, 3 mM MgCl2, 200 M dATP, 200 M dCTP, 200 M
dGTP, 200 M dTTP (Sigma), 5 ng of purified PCR product from the previous
mutagenic reaction, 25 pmol of primer 5GAD424, 25 pmol of primer
3GAD424, and 1.25 U of Taq polymerase (Promega). The reaction was run
under conditions identical to the previous reaction. The single PCR product was
gel extracted, quantified by UV spectroscopy, and digested with EcoRI and SalI
(Roche Molecular Biochemicals). The product was ligated into pGAD424 which
had been cut with EcoRI and SalI, dephosphorylated with shrimp alkaline phos-
phatase (Roche Molecular Biochemicals), and gel purified. The ligation product
was electroporated into Escherichia coli (Epicurean Coli XL1-Blue; Stratagene).
Resulting colonies were scraped into Luria-Bertani (LB) broth, and plasmid
DNA was extracted with a Qiaprep spin miniprep kit (Qiagen).
Evaluation of clones. (i) -Galactosidase colony-lift filter assay. The mutant
library plasmid DNA was transformed into yeast strain YM4271[E1BST-LacZi]
(hereafter referred to as YM4271[E1BST]) using a Frozen-EZ Yeast Transfor-
mation II kit (Zymo Research). Colonies were grown at 30°C on synthetic
dropout medium plates lacking uracil and leucine and then lift-transferred onto
nitrocellulose filters (Schleicher & Schuell). Filters were frozen in liquid nitro-
gen, thawed, and incubated on top of filter paper soaked in buffer containing 60
mM Na2HPO4  7H2O, 40 mM NaH2PO4  H2O, 10 mM KCl, 1 mM MgSO4 
7H2O, 0.2% -mercaptoethanol, and 265 g of 5-bromo-4-chloro-3-indolyl--D-
galactopyranoside (X-gal) at 30°C for 3 h. The E1DBD open reading frame
(ORF) was sequenced in reporter-negative colonies as described below. Selected
reporter-negative clones were transformed into the control yeast reporter strain
YM4271[p53BLUE] and assayed on nitrocellulose filters for reporter activity.
(ii) SSCP assay. Subsequent to filter assays, 60 reporter-positive yeast colonies
were cultured and plasmid DNA was extracted with a Zymoprep yeast plasmid
miniprep kit (Zymo Research). Two sets of primers were used in separate 50-l
PCRs to amplify and label the 5 and 3 halves of the E1DBD ORF from each
clone. Oligonucleotide primers SSCP1 (5-CCAAAAAAAGAGATC-3), SSCP2
(5-ATGAGATCTTTTTTGC-3), SSCP3 (5-GTTTCGAACTCCTAA-3), and
SSCP4 (5-TTCATAGATCTCTGC-3) were purchased from the Texas A&M
University Veterinary Pathobiology Core Facility. Reactions contained 10 mM
Tris-HCl (pH 9.0) at 25°C, 50 mM KCl, 0.1% Triton X-100, 3 mM MgCl2, 200
M dATP, 200 M dCTP, 200 M dGTP, 200 M dTTP (Sigma), 1.25 l of
template plasmid DNA extracted from yeast, 1.5 pmol of each primer from the
SSCP1/SSCP2 primer pair or SSCP3/SSCP4 primer pair (Sigma-Genosys), and
0.25 U of Taq polymerase (Promega) in a 12.25-l reaction volume. Ten micro-
liters of each reaction product was added to 2 l of single-strand conformation
polymorphism (SSCP) sample buffer, which was made by combining 9.5 ml of
deionized formamide, 0.4 ml of 0.5 M EDTA (pH 8.0), 0.05 ml of 10% bromo-
phenol blue, and 0.05 ml of 10% xylene cyanol. Samples were boiled in a water
bath for 5 min and immediately transferred to ice for 2 min. Samples were
electrophoresed for 8 h at 350 V on an 8% polyacrylamide gel containing 5%
glycerol and maintained at 19°C. The gel was dried and imaged using a Molecular
Dynamics Phosphorimager. Samples which exhibited altered gel mobilities com-
pared to a control were sequenced as described below.
(iii) Temperature-sensitive screens. The mutant libraries of pGAD-E1DBD
were transformed into yeast strain YM4271[E1BST] and plated on synthetic
dropout medium lacking uracil and leucine. Colonies were grown at 39°C for 1
week and then assayed for reporter activity by the filter assay described above.
The same colonies were then grown for 3 additional days at 30°C and examined
again for reporter activity by filter assay. Results at 30 and 39°C were compared,
and colonies which were reporter positive at 30°C and reporter negative at 39°C
were selected. Plasmid DNA was then extracted and sequenced as described
below.
(iv) DNA sequencing. Yeast colonies were cultured and plasmid DNA was
extracted using a Zymoprep yeast plasmid miniprep kit (Zymo Research). For
reporter-negative clones, PCR was used prior to DNA extraction to confirm the
presence of E1DBD ORF in the plasmid. After extraction, plasmid DNA was
electroporated into E. coli (Epicurean Coli XL1-Blue; Stratagene). The E1DBD
ORF was sequenced using an ABI Big Dye Terminator DNA sequencing kit (PE
Biosystems) with primers against the pGAD424 plasmid, 5GAD424, and
3GAD424 (sequences listed above).
Purification of GST-E1DBD and E2 protein. The E1DBD coding region from
pGAD424-E1DBD mutants F175S, N184Y/K288R, D185G, V193M, F237L,
K241E, R243K, and V246D was subcloned into pGEX-5X-1 (Pharmacia) using
the same EcoRI and SalI sites used to create the pGAD424-E1DBD mutant
library. The subclones were electroporated into E. coli strain BL21 and verified
by PCR and restriction digestion. Fusion proteins were purified as previously
described (12).
For E2 purification, BL21 E. coli containing pGEX-4T-E2 (expresses gluta-
thione S-transferase [GST]-E2 fusion protein with thrombin cleavage site) was
grown in 200 ml of 2XYT broth containing 100 g of ampicillin, which was
inoculated with a 20-ml overnight culture and grown for 3 h at 37°C with shaking
at 225 rpm. The culture was induced with 100 mM IPTG (isopropylthiogalacto-
pyranoside) to a final concentration of 1 mM and grown for another 2 h at 37°C
with shaking at 225 rpm. Cells were centrifuged at 5,000  g for 10 min, and the
pellet was frozen at 20°C overnight. The pellet was thawed for 30 min on ice
and resuspended in B-PER reagent (Pierce) with 5 mM dithiothreitol (DTT) and
1 mM phenylmethylsulfonyl fluoride (PMSF). Lysozyme was added to a concen-
tration of 100 g/ml, and the suspension was rotated end over end at 4°C for 1 h.
The sample was sonicated twice for 15 s using an Ultrasonics sonicator with the
microtip at maximum power and then centrifuged at 20,000 g for 30 min at 4°C.
Two hundred microliters of glutathione-Sepharose 4B beads (Pharmacia) was
added to the supernatant, which was then rotated overnight at 4°C. Beads were
washed twice with GST-C buffer (50 mM Tris-HCl [pH 7.9], 250 mM NaCl, 5
mM EDTA, 10% glycerol) plus 5 mM DTT and 10 mM PMSF, twice with GST-E
buffer (50 mM Tris-HCl [pH 8.0], 1 M NaCl, 5 mM EDTA, 10% glycerol) plus
5 mM DTT and 10 mM PMSF, and a final wash twice in GST-C buffer. GST-E2
bound to glutathione-Sepharose beads was cleaved using 5 NIH units of throm-
bin in 425 l of phosphate-buffered saline overnight at room temperature. Beads
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were centrifuged at low speed, and supernatant containing cleaved E2 was
removed and stored at 20°C. Cleavage and integrity of the E2 protein were
verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis.
In vitro DNA binding assays. The concentration of wild-type GST-E1DBD
protein was determined by the Bradford assay (5). The concentrations of mutant
GST-E1DBD proteins were estimated by Coomassie blue staining of acrylamide
gels followed by densitometry and comparison to a known amount of wild-type
protein. In vitro binding was assessed by a gel shift assay using a blunt-ended,
double-stranded oligonucleotide comprising BPV-1 nucleotides 7926 to 29 as
previously described (12, 37). Except where indicated otherwise, 10 ng of each
wild-type or mutant GST-E1DBD protein was used in the binding assays; where
E2 was also included, typically 20 ng of purified protein was used.
In vivo DNA replication assays. Mutations were constructed in heterologous
expression vector pCGE1 for expression of full-length E1 mutants F175S,
N184Y, D185G, V193M, F237L, K241E, R243K, and V246D. Heterologous
expression vectors pCGE1 and pCGE2 at 1.0 and 0.1 g, respectively, were
mixed with 1.0 g of the BPV origin-containing vector pBOR or 1.0 g of pUC18
FIG. 1. Summary of E1DBD mutations. (A) E1 amino acid sequence from residues 150 to 304. The locations of -helices and -sheets derived
from the crystal structure (10) are diagramed above the sequence, along with the positions of the previously described hydrophilic regions HR1
and HR3 (12). Below the sequence are the origin-nonbinding ( row, squares) and origin-binding ( row, triangles) mutants from this study (solid
symbols) and our previous study (open symbols). (B) Three-dimensional ribbon diagram of E1 protein residues 159 to 303 from Enemark et al.
(10). Residues whose mutation yields a nonbinding phenotype in the yeast one-hybrid assay are indicated in red on the left monomer, and
binding-positive mutations are in blue on the right monomer. The boundaries of the HR1 loop region are indicated with red arrows, and the HR3
region boundaries in -helix 4 are indicated with blue arrows. Specific amino acid positions characterized in detail in the text are indicated (note
that V246 is on the posterior side of -helix 4 and is not visible in this figure).
11950 WEST ET AL. J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
for positive and negative controls, respectively. Similar mixtures were made with
each pCGE1 mutant, pCGE2, and pBOR. The combined DNAs were transected
into Chinese hamster ovary (CHO) cells using the Lipofectamine transfection
reagent (Gibco-BRL). At 48, 72, and 96 h posttransfection, plasmid DNA was
harvested by Hirt extraction and digested with DpnI and HindIII (New England
Biolabs). DNA samples were electrophoresed on an 8% agarose gel, transferred
to a Nytran Supercharge nylon membrane (Schleicher & Schuell) by Southern
transfer, and cross-linked to the membrane using a Stratalinker (Stratagene). A
pBOR probe was radiolabeled using the Prime-a-Gene labeling system (Pro-
mega) and hybridized to the membrane using Rapid Hyb buffer (Amersham).
The membrane was analyzed by Phosphorimager analysis.
RESULTS
Mutations in and near HR1 and HR3 decrease E1DBD-
dependent reporter activity in yeast cells. We previously de-
scribed the development of a yeast one-hybrid system for mon-
itoring sequence-specific interactions of both full-length E1
and the E1DBD with chromosomal DNA containing three
tandem E1 binding sites (E1BST) upstream of the lacZ gene
(12) (Fig. 2A). Reporter gene expression in this system re-
quires specific E1-E1BS interaction, as neither the pGAD424
parental in the YM4271[E1BST] strain nor the pGAD424-
E1DBD construct in YM4271[p53BLUE] (which contains a
p53 binding site instead of the E1 binding sites) is sufficient for
-galactosidase production.
In order to generate unbiased genetic data of the amino acid
requirements for E1 DNA binding, we generated two libraries
of mutations in the E1DBD ORF by a PCR random mutagen-
esis procedure (31). After cloning the PCR products into
pGAD424, the libraries were screened using the yeast one-
hybrid system, and mutant clones which failed to activate the
reporter gene, suggesting possible defects in DNA binding,
were isolated (Fig. 2B). Our first library was made using lim-
iting amounts of dATP to drive dITP incorporation and re-
sulted in clones with an average substitution frequency that
was too high for easy identification of the critical residues
(Table 1, A clones). Our second library was made using limit-
ing dGTP and resulted in a lower substitution frequency of
about one to two mutations per clone (Table 1, G clones, and
Table 2, BG clones). This second library was used for the
remaining studies reported here.
Approximately half of 84 reporter-negative colonies that we
selected from filter screens of the second library tested positive
for the E1DBD insert by PCR, and approximately 65% of the
insert-containing clones had appropriate restriction digestion
profiles. These clones were sequenced to identify the muta-
tions present (Table 1), and the mutant residues are depicted
on the E1DBD structure in Fig. 1. Additionally, mutant clone
G75 (V193M) was isolated in a yeast two-hybrid screen of the
E1DBD library for mutants which fail to interact with an E1
fragment, E11–311, which normally interacts with the wild-type
E1DBD (K. Woytek, unpublished data). This mutant was sub-
sequently assayed in our yeast one-hybrid system and failed to
activate the E1DBD-dependent reporter. All mutants were
also transferred into strain YM4271[p53BLUE] to confirm
that they are unable to activate the p53-dependent reporter
gene by any spurious activity.
Considering only single-, double-, and triple-point mutants,
we identified 22 new mutants with 34 amino acid positions
altered and 36 total substitutions. Eleven of 34 positions (34%)
mapped to the HR1 and HR3 regions. However, this number
may be an underestimate, since some mutations present in
double and triple mutants are likely nonessential for DNA
binding. Consequently, if only single and double mutants are
considered, we have 19 mutations and can discount substitu-
tions at positions 137, 139, and 288 because 137 and 139 are
outside the sequences required for DNA binding and 288 is
functional when tested separately (not shown). Thus, we are
left with 16 mutations causing DNA binding defects, of which
8 (50%) are located in HR1 and HR3.
Nonessential residues are rare in and near HR1 and HR3.
We also screened the libraries for binding-functional E1DBD
mutants using two different methods. First, we examined re-
porter-positive yeast clones for SSCP. Following plasmid DNA
extraction from the yeast clones, we generated PCR products
from the E1DBD ORF, which were then processed as de-
scribed in Materials and Methods and examined on native
polyacrylamide gels (Fig. 2C). Of 60 clones screened, 21 (35%)
were found to display SSCP. Second, we used a temperature
sensitivity screen by performing reporter assays at both 30 and
39°C. Using this method, we screened approximately 300
clones and found four mutant candidates (1.3%). Upon se-
quence analysis of clones which displayed conformation poly-
morphisms or temperature sensitivity, we identified a variety of
mutations which were scattered throughout the E1DBD (Ta-
ble 2 and Fig. 1). These binding-functional mutations were
largely absent from the HR1 and HR3 regions, with a few
exceptions which may represent functional papillomavirus
polymorphisms or simply nonconserved residues (see Discus-
sion). Furthermore, the paucity of nonsense and frameshift
mutations in reporter-positive clones compared to reporter-
negative clones is consistent with this tested E1 polypeptide
being a minimized DNA binding domain.
From our screens of reporter-positive mutants, we isolated
13 new mutants with 20 amino acid positions altered and 20
total substitutions. Between residues 140 and 311, we found 19
mutations, for an average of one substitution every nine resi-
dues, only one (5%) of which mapped to HR1 or HR3, D185N
in clone BG14. This is a conservative alteration at a residue
nonessential for in vitro DNA binding, as shown by alanine
substitution (12). Using a chi-square test with 1 degree of
freedom, we compared the frequency of HR1 and HR3 muta-
tions in reporter-negative and reporter-positive clones based
on white clones with 8 of 16 mutations in HR1 or HR3 and
blue clones with 1 of 19 mutations in HR1 or HR3. The higher
number of HR1 and HR3 mutations in the nonbonding clones
compared to the functional clones was statistically significant,
with a P value of 0.005. This strongly supports the previously
demonstrated importance of these two regions for origin rec-
ognition by the E1 protein.
HR1- and HR3-associated mutations affect sequence-spe-
cific DNA binding in vitro. Since we isolated the mutants by in
vivo screening, it was important to test them in vitro for con-
firmation of their binding negativity as well as to control pro-
tein amounts, which may vary with expression in vivo. In a
previous study we examined five substitution mutants of HR1
(K183A, D185A, K186A, T187A, and T188A) but only one
mutant of HR3 (K241A). Our current yeast screens yielded
two new mutations in HR1 (N184Y and D185G) and three
new mutations in HR3 (K241E, R243K, and V246D), which
gave us the opportunity to examine HR3 in more depth. In
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addition, the screen also identified several nonfunctional mu-
tations which resided outside the HR1 and HR3 sequences.
Mutants F175S, V193M, and F237L neighbor HR1 or HR3
and were chosen for additional study. Mutations at positions
210, 265, and 293 involved adding or removing a proline, which
is likely to disrupt structure, and were not investigated further.
Mutation S207C lies in the 3 helix and may be critical for
dimerization of the E1DBD (10), and will be characterized as
part of a later study.
The reporter-negative mutants F175S, N184Y/K288R,
D185G, V193M, F237L, K241E, R243K, and V246D from our
yeast screen were subcloned into pGEX (Pharmacia) for ex-
pression of GST fusion proteins in E. coli. The only double
mutant included for in vitro study was selected because of the
FIG. 2. Yeast one-hybrid screening system and representative data. (A) Expression of yeast GAL4 transactivation domain (GAL4AD) fused
to the E1 DNA binding domain (E1DBD) activates a lacZ reporter gene upon interaction of the E1DBD with three tandem copies of the E1
binding site (E1BST). (B) Nitrocellulose filter assay for reporter activity in yeast colonies harboring pGAD424-E1DBD constructs.
YM4271[p53BLUE] is a control strain containing a p53 binding site in lieu of E1 binding sites, which confirms that interaction between the E1DBD
and E1BST is sequence specific. Shown are both reporter-positive and reporter-negative mutants from our screens along with their genotypes. (C)
SSCP assay was used to detect mutations in the E1DBD coding regions of reporter-positive yeast colonies. PCR was used to amplify and radiolabel
the 5 and 3 halves of the 573-bp E1DBD open reading frame of wild-type pGAD424-E1DBD and candidate mutants. PCR products were then
processed as described in Materials and Methods and electrophoresed on native polyacrylamide gels. Samples from the 5 and 3 amplimers are
shown in the right and left panels, respectively. Lane designations are the clone names as listed in Table 2. Lanes marked C were amplified from
the parental wild-type E1DBD clone.
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presence of substitution K288E in a binding-functional mutant
(clone BG28, Table 2), which makes it likely that N184Y is the
mutation critical for DNA binding. Purified wild-type and mu-
tant E1DBD proteins were compared for DNA binding activity
using a radiolabeled oligonucleotide substrate (BPV nucleo-
tides 7926 to 29) containing the E1 binding site and E2 binding
site 12. As previously described, wild-type E1DBD bound this
substrate and produced multiple E1DBD-DNA complexes
(12). All E1DBD mutants were observed to have greatly re-
duced binding affinity for the probe compared to the wild type,
confirming the in vivo results that the mutated residues were
critical for sequence-specific DNA interaction (Fig. 3). How-
ever, mutants D185G, F237L, and R243K formed a detectable
though still not wild-type level of complex with the probe at
higher protein concentrations (data not shown and Fig. 4).
The weak binding activity of these three mutants suggested
that they may still be capable of cooperative interaction with
E2, so the in vitro DNA binding assays were repeated in the
presence of bacterially purified E2 (Fig. 4). E1DBD-E2-DNA
complexes were detected for all three of the mutants, though
not for N184Y/K288R, which does not exhibit any origin bind-
ing in the presence or absence of E2. These results indicate, at
least in some cases, that protein-protein interactions between
the E1DBD and E2 are sufficient to stabilize very poor inter-
actions between the E1DBD and its binding sequence.
E1DBD mutants positive for E2 interaction support partial
in vivo DNA replication. The ability of some binding-defective
mutants to be rescued by E2 suggested that they may retain
sufficient function to support DNA replication. Single point
mutations F175S, N184Y, D185G, V193M, F237L, K241E,
R243K, and V246D were constructed in the vector pCGE1,
which expresses full-length E1 in mammalian cells for in vivo
DNA replication assays. The N184Y mutation was separated
from K288R in this experiment so that substitution at residue
184 was the only change present in E1. Heterologous expres-
sion vectors pCGE1 (wild-type or mutant) and pCGE2 were
transfected along with the BPV-1 origin-containing plasmid
pBOR into Chinese hamster ovary cells. Plasmid DNA was
Hirt extracted at 48, 72, and 96 h posttransfection and exam-
ined by Southern blotting as described in Materials and Meth-
ods (Fig. 5A). DpnI-resistant replication products were quan-
tified by Phosphorimager analysis, and a minimum of two
independent transfections were performed for each mutant
construct. From each experiment, replication efficiencies were
calculated as the percentage of replication product made in the
presence of wild-type E1, and the average replication efficien-
cies are plotted in Fig. 5B.
Mutants E1D185G, E1F237L, and E1R243K supported 19, 51,
and 72% of wild-type replication, respectively. In contrast to
these three mutants, which supported significant levels of DNA
replication, mutants E1F175S, E1N184Y, E1V193M, E1K241E, and
E1V246D, which were unable to form E1-E2-DNA complexes in
vitro, supported little if any replication. Thus, only those
E1DBD mutants which retained functional interaction with E2
in vitro could support replication activity as full-length E1
mutants. This result is consistent with the recent report that E2
mutations which specifically prevent interaction with the
E1DBD also reduce in vivo DNA replication (7, 11).
HR3 is unlikely to make the majority of base contacts with
DNA. The distribution of functional versus nonfunctional mu-
tations described above strongly implicates HR1 and HR3 as
TABLE 1. Mutations in the E1DBD ORF of reporter-negative
yeast clonesa
Mutation class Clone Mutation(s)
One substitution G2 P293H
G6 L210P
G13 F237L
G21 S207C
G22 F175S
G31 P265S
G34 K241E
G51 D185G
G56 R243K
G67 V246D
G75 V193M
Two substitutions A33 E139D, T187S
G1 R137W, K186E
G26 N184Y, K288R
G38 R247Q, W277G
G44 F203V, P265L
Three substitutions A11 H150P, K155I, L172P
A34 Q144R, T188P, N189D
G3 A159T, N184K, A206V
G17 F203V, Q219L, Q299R
G25 C173S, N252S, L261S
G30 F203V, W277R, L306S
More than three
substitutions
A37 R123H, T187A, F204S, Q307R
A3 D185G, T187A, S224F, V256I,
S281G, K288E
Premature
termination codon
A32 221STOP
G10 212STOP
G24 144STOP
G46 152STOP
G48 264STOP
G62 219STOP
Deletion/frameshift A1 Codon 241
G11 Codon 158
G69 Codon 265
Insertion/frameshift None
a Underlined mutants were selected for in vitro analyses.
TABLE 2. Mutations in the E1DBD ORF of reporter-positive yeast
clonesa
Mutation class Clone Mutation(s)
One substitution BG3 E205V
BG13 F175Y
BG16 S174R
BG20 A291T
BG30 I268S
BG33 C236S
BG37 Q214L
BG47 S283L
Two substitutions BG4 G136E, A159V
BG28 F197L, K288E
GTS4 N238I, L275P
Three substitutions BG14 D185N, E258G, F278S
GTS3 G227E, E259V, H289R
Premature termination
codon
GTS1 Codon 190b
Deletion/frameshift None
Insertion/frameshift None
a Underlined mutants represent potential papillomavirus polymorphisms.
b This mutant is suspected to display terminator codon readthrough.
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critical elements for sequence-specific E1-DNA interaction,
but does not discriminate the individual roles of each element.
We noted previously that the organization of these two E1
elements resembled that of the A and B2 regions of SV40 T
antigen, which are similarly critical for sequence-specific DNA
binding (12). The recent crystal data for the E1DBD confirmed
an overall structural similarity between the T antigen and E1
DNA binding domains (10), and a manual alignment of the
primary sequences shows a remarkable relatedness, particu-
larly in the DNA interaction elements (Fig. 6A).
Interestingly, the EBNA1 protein also uses two motifs sep-
arated by approximately 50 residues in the linear sequence,
called the flanking domain and recognition helix, for specific
binding to an 18-bp sequence in the Epstein-Barr virus origin
(1, 4, 9). The EBNA1 flanking domain is an extended loop
which makes base contacts, while the recognition helix makes
nonspecific phosphate contacts (4). Thus, EBNA1 achieves
sequence-specific DNA binding using a site-specifying base
interactor and a nonspecific phosphate interactor. Though less
distinctive than between E1 and T antigen, there is intriguing
sequence similarity between the EBNA1 flanking domain and
HR1/A, and between the EBNA1 recognition helix and
HR3/B2 (Fig. 6B). In addition to the sequence similarity, the
corresponding elements have common secondary structures,
with the flanking domain/HR1/A elements all located in loops
while the distal elements for all three proteins form helices.
FIG. 3. In vitro analysis of GST-E1DBD interactions with a 50-bp double-stranded, sequence-specific DNA probe. (A) GST-E1DBD fusion
proteins were purified by glutathione-Sepharose affinity chromatography. Shown are 10% polyacrylamide gels containing wild-type and mutant
proteins and stained with Coomassie blue. Lanes M, size markers. (B) Electrophoretic mobility shift assay of wild-type (WT) and mutant
GST-E1DBD fusion proteins. For each reaction, 10 ng of protein was incubated with the radiolabeled DNA except for mutant V246D, for which
3 ng was used in this experiment.
11954 WEST ET AL. J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
These physical parallels suggest common functions and impli-
cate HR3 as the DNA backbone binding unit rather than the
base-specific contact element.
To assess the functional contribution of HR3 to sequence-
specific DNA binding, we generated a chimeric triple mutant
called THR3 to test for retention of sequence-specific DNA
binding in the yeast one-hybrid system (Fig. 7A). THR3 con-
tains three residues from T antigen element B2 which were
simultaneously substituted into E1 HR3 (S242H/E244V/
T245S). The rationale for this construct was that if HR3 made
specific base interactions, then multiple amino acid substitu-
tion should disrupt the ability to recognize the E1BS. Con-
versely, if the role of HR3 were more in nonspecific DNA
contact, then substitution with the corresponding residues
from T antigen should not eliminate binding to the E1BS
sequence. The results shown in Fig. 7B demonstrate that the
mutant retained sequence-specific binding capacity in vivo. In
a separate construct, we also observed that a site-directed
single mutation in HR3, V246A, functioned in yeast cells (not
shown).
To further assess the functionality of THR3, the mutant
protein was purified and tested in the in vitro DNA binding
assay (Fig. 7C). While reduced in activity compared to wild-
type E1DBD, the THR3 protein demonstrated significant se-
quence-specific binding ability and wild-type levels of E1DBD-
E2-DNA complex formation. Consistent with its DNA binding
properties, in the context of full-length E1, the THR3 muta-
tions still allowed in vivo replication at 	25% of wild-type
levels (data not shown). Since both THR3 and V246A main-
tained sequence-specific DNA binding, residues S242, E244,
T245, and V246 are not absolutely critical for sequence spec-
ificity of the E1DBD. The ability to alter the majority of resi-
dues in HR3 without loss of sequence-specific binding activity
or without complete loss of replication function is more con-
sistent with this element’s providing nonspecific contacts than
base recognition.
DISCUSSION
We previously used site-directed mutagenesis to show that
mutations in E1DBD elements HR1 and HR3 disrupt se-
quence-specific interaction with the DNA origin. In our cur-
rent study, we used random PCR mutagenesis along with a
yeast one-hybrid screen to identify additional mutants of the
BPV-1 E1DBD which are defective for sequence-specific DNA
interactions. As a complement, binding-functional mutants
were also identified. Our goal in using this nondirected ap-
proach was to gain a more extensive understanding of the
location and specific function of those amino acids most im-
portant for the origin-binding activity of E1.
The locations of the various binding-functional and -non-
functional mutations are indicated on the E1 sequence and
structure in Fig. 1, and the properties of selected nonbinding
mutants are summarized in Table 3. While the mutations were
mostly characterized in the context of the isolated E1DBD,
two random and five site-directed mutations were subsequently
analyzed in full-length E1 using the yeast one-hybrid system
(data not shown). All seven mutations, four binding functional
and three nonfunctional, had the same binding phenotypes in
the E1DBD compared to full-length E1. Thus, the E1DBD
seems to be a truly independent domain in E1, and results with
the E1DBD should be generally reflective of the properties of
full-length E1 for DNA interaction.
Residues necessary for sequence-specific DNA binding by
E1 are concentrated in and near HR1 and HR3. Using the
recently published crystal structure (10), previous studies of T
antigen mutants (29, 30), and our new mutant data, we have
arrived at several conclusions regarding possible functions of
specific E1DBD residues. The first observation to emerge from
sequence comparisons of the E1DBD ORF in reporter-nega-
tive yeast clones was the repeated occurrence of substitutions
in and around the HR1 and HR3 regions (Fig. 1). Further-
more, a chi-square statistical test indicated that the clustering
of critical mutations in HR1 and HR3 for the reporter-nega-
tive clones versus the reporter-positive clones had a less than
0.5% probability of occurring by chance. This correlation is
further evidence that hydrophilic regions HR1 and HR3 are
indeed necessary for sequence-specific DNA binding. Besides
the HR1 and HR3 regions, the only other modest clustering of
nonfunctional mutations occurred in -helix 3. This helix is
involved in E1 dimerization, and the occurrence of several
FIG. 4. In vitro E2-mediated rescue of DNA binding by E1DBD mutants. Electrophoretic mobility shift assays were performed as in Fig. 3 using
the amounts of proteins (in nanograms) indicated. The other single-substitution mutations shown in Fig. 3 were all negative for E2 rescue in this
assay (not shown).
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mutations in this region supports an important functional role
for E1-E1 contacts in origin binding. As expected, functional
mutations isolated from the reporter-positive clones were
more evenly distributed throughout the E1DBD.
Role of HR1 residues in E1DBD-DNA interaction. Our pre-
vious study identified a cadre of hydrophilic residues in HR1
that were critical for origin binding (12). The recently pub-
lished crystal structure of the E1DBD revealed that the HR1
FIG. 5. DNA replication in CHO cells. (A) Representative Southern blots of replication products recovered from CHO cells at 48, 72, and 96 h
posttransfection. Cells were triple transfected at time zero with vectors for E1 and E2 expression and a plasmid containing the BPV origin, pBOR,
or pUC18 as a non-origin-containing control. Wild-type (WT) and mutant E1 expression vectors were used as indicated. (B) Quantitation of DNA
replication products. Band intensities on Southern blots were measured by Phosphorimager analysis. Replication efficiency of mutant E1 proteins
was calculated by comparing the intensity of wild-type and mutant replication product bands at 96 h posttransfection. Average replication
efficiencies for two or more independent experiments are shown. Data for V193M were generated in a separate study.
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region forms a structurally well-defined loop which potentially
makes sequence-specific contacts with origin DNA (10). In the
current study, two new mutations in HR1 were characterized,
N184Y and D185G. N184Y was analyzed in the context of the
double mutant E1DBDN184Y/K288R; however, the K288R sub-
stitution is unlikely to be the critical change for disrupting
DNA binding, since a nonconservative change at this position
appeared in a binding-functional mutant (Table 2). Addition-
ally, the single point mutant E1N184Y exhibited a severe defect
for in vivo DNA replication in CHO cells. Therefore, the
N184Y substitution is most likely responsible for the defective
DNA interaction both in vivo and in vitro as well as for E2
binding in vitro.
We do not suspect that the N184Y mutation in either
E1DBD or full-length E1 caused severe misfolding, as we
observed other wild-type activities for the mutant, including
nonspecific DNA binding in the absence of pUC18 nonspecific
competitor DNA and single-stranded DNA binding (data not
shown). It also seems unlikely that N184Y would affect global
protein folding, since it is both a surface residue and not part
of any defined secondary structure such as an -helix or
-sheet. However, the majority of E1 proteins have either a
serine or asparagine at positions corresponding to 184, sug-
gesting that a polar side chain able to support hydrogen bond-
ing is required at this position. While tyrosine has chemically
similar properties, the much bulkier tyrosyl group may cause
steric hindrance that would prevent proper alignment of HR1
with the base sequences.
E1DBDD185G is also severely defective for sequence-specific
DNA binding, but at higher protein concentrations it does
exhibit some activity. Additionally, this mutant is capable of in
vitro E2 interaction and supports approximately 20% of the
wild-type E1 in vivo DNA replication. As with N184Y, this
partial functionality again suggests that tertiary structure is not
completely disrupted by this amino acid change. A previously
examined mutation at this position, E1DBDD185A, is even less
FIG. 6. (A) Sequence alignment between DNA binding domains of SV40 T antigen and BPV-1 E1. Boxes indicate regions of sequence
similarity. There is an extended -hairpin in E1 at residues 223 to 230 which is not found in T antigen. The locations of conserved regions HR1,
HR3, A, and B2 are indicated. (B) HR1- and HR3-like elements are found in origin-binding proteins from three transforming DNA viruses:
papillomavirus, SV40, and Epstein-Barr virus. E1, T antigen (T-AG), and EBNA1 contain regions of sequence similarity which are separated by
approximately 50 amino acid residues and which are critical for sequence-specific DNA binding.
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defective and supports 30 to 50% of wild-type sequence-spe-
cific DNA binding (12). In the crystal structure, the side chain
of D185 interacts with R243 and contributes to the coupling of
HR1 and HR3 (10). The reduced but still significant function-
ing of the D185A and D185G mutants indicates that the co-
ordinating bond between D185 and K243 is important but not
absolutely essential to maintain correct juxtaposition of HR1
and HR3; presumably the interaction between K243 and F182
remains and provides sufficient stability for modest function.
The more dramatic defect of E1DBDD185G compared to the
D185A mutant likely results from the greater conformational
flexibility inherent in glycine residues. Thus, the presence of
glycine at position 185 may disorder the loop structure and
alter the positioning of side chains at nearby residues. This may
both disrupt the structurally stabilizing F182-K243 interaction
and disturb possible base-specific contacts by critical residues
such as K183, N184, K186, and T187.
Role of HR3 residues in E1DBD-DNA interaction. We also
isolated and characterized new mutations in the HR3 element.
Mutant K241E was defective for in vivo and in vitro binding,
E2 interaction, single-stranded DNA binding (unpublished
data), and in vivo DNA replication. Residue K241 resides at
the N-terminal side of -helix 4, contributes a positively
charged amino group, and lies on the DNA binding surface of
E1. Substitution of a negatively charged glutamic acid residue
likely increases electrostatic repulsion between this position
and the DNA backbone, though this does not exclude that the
lysine might also normally make specific base contacts.
Another mutant, R243K, was interesting and unique be-
cause it was severely crippled for DNA binding despite having
a conservative amino acid change. Consistently, an earlier
study showed that the same conservative mutation at the cor-
responding T antigen residue, R204 (Fig. 6A), had a severe
effect on sequence-specific DNA binding, more so than did
substitutions at nearby residues V205 and A207 (29). Crystal
data for the E1DBD show that R243 makes a total of four
contacts, two with the HR1 residues D185 and F182, and two
additional ones with Q264 and L263 (10). Since the net posi-
tive charge is unchanged by the lysine substitution, the most
likely explanation for the functional defect seems to be the loss
of an amino group. Loss of this moiety effectively reduces the
number of potential contacts that can be made simultaneously
and likely cripples this anchoring point for the HR1 region.
While failure to maintain correct positioning of HR1 and HR3
would explain the binding defect, this mutant still formed
E1DBD-E2-DNA complexes, bound single-stranded DNA
(data not shown), and had nearly wild-type ability to support
DNA replication in vivo. These results are consistent with
retention of a generally correct tertiary structure and also
suggest that additional interactions, either from E2 or from
other regions of full-length E1, can somewhat compensate for
the lost contacts at residue 243. Nonetheless, among the E1
proteins from all papillomavirus groups and the T antigen
proteins from all polyomavirus groups, the arginine 243 posi-
FIG. 7. (A) Sequence alignment between E1 HR3 and SV40 T
antigen (TAG) region B2. Also shown is the sequence in the HR3
region of the THR3 mutant. Multiple site-directed substitutions were
made to create this chimeric mutant of the E1DBD whose HR3 ele-
ment contains residues found in the T antigen B2 element. (B) Nitro-
cellulose filter assay showing sequence-specific interactions between
THR3 and E1 binding sites in the yeast one-hybrid system. (C) Elec-
trophoretic mobility gel shift assay as in Fig. 4, showing cooperativity
of binding of THR3 with E2 on an origin-specific DNA probe.
Amounts of proteins (in nanograms) are indicated.
TABLE 3. Functional properties of DNA-binding-defective
E1DBD mutants
E1DBD
Sequence-specific
DNA binding
E1DBD-E2
binding in
vitro
In vivo DNA
replication
(% of wild-type level)In vivo In vitro
Wild-type    100
F175S    0.2
N184Y/K288R    3.9
D185G Weaka Weakb Weak 18.9
V193M    0
F237L    50.8
K241E    0.3
R243K Weaka Weakb Weak 71.8
V246D    0
a Less than 5% of retransformed yeast colonies were reporter positive.
b Protein-DNA complexes were observed at increased protein concentrations.
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tion is a highly conserved residue, which is consistent with its
providing an important stabilizing function.
The last mutation in HR3 that was identified by the one-
hybrid screen was V246D. It does not appear that the valine
residue is critical for specific base contacts, as a V246A mutant
was significantly functional in vivo (unpublished data). Conse-
quently, like K241E, introduction of a negative charge at this
V246 may simply cause repulsion between this position and the
similarly charged phosphodiester backbone of the DNA. Al-
ternatively, V246 may actually help stabilize the DNA contact
motifs. The crystal structure demonstrates the proximity of
residues F237 and V246 in a hydrophobic pocket just beneath
the E1DBD DNA binding surface. As an F237L mutant also
showed reduced DNA binding in vivo and in vitro, decreased
hydrophobicity at these residues may affect nonpolar interac-
tions which potentially alter HR1 and HR3 positioning. The
potential role of core hydrophobic residues in architectural
support of the DNA contact motifs is currently being studied in
more detail.
To further investigate the role of HR3, a triple substitution
mutant, THR3, was constructed. This mutant retained in vivo
DNA binding activity, indicating that none of the changed
bases, S242, E244, or T245, was absolutely essential for se-
quence-specific binding. The ability to replace at least four of
the HR3 residues (THR3 mutations plus the V246A mutant)
without total loss of sequence-specific recognition function,
along with a structural coordination role for R243, seems in-
consistent for a region designed to make specific base contacts
with DNA. Therefore, we propose that HR3 is primarily re-
sponsible for making phosphate backbone contacts, like the
EBNA1 recognition helix. Such a role would be consistent with
the severe binding defect which resulted from introducing
acidic residues at positions 241 and 246. In contrast, multiple
conserved residues in HR1 (R180, K183, N184, D185, K186,
and T187) are associated with critical single point mutations,
suggesting that HR1 is a better candidate for a sequence rec-
ognition device.
Role of critical residues outside the HR1 and HR3 regions.
Other than substitutions at proline residues (P265 and P293),
which likely severely disrupt overall structure, binding-critical
residues outside HR1 and HR3 fell into two groups: hydro-
phobic amino acids (F175, V193, F237, and W277) and resi-
dues located in -helix 3 (F203, S207, and L210). From the
crystal structure, it appears that these hydrophobic residues
may contribute to a core that forms a scaffold beneath the
HR1/HR3 structure and possibly provides an anchor function
for the DNA interaction motif. A more detailed study of the
role of this hydrophobic core will be presented elsewhere (un-
published data).
The 3 helix has been shown to be a functional dimerization
interface for the E1DBD (10), and we identified two single
substitution mutations in this region, E1DBDS207C and
E1DBDL210P, that were reporter negative in the yeast one-
hybrid screen. Additionally, an F203V mutation showed up in
three different reporter-negative clones, though all had double
or triple mutations, so the contribution of the F203V mutation
to the functional defect has not been specifically established.
While none of these single or multiple mutants has been ex-
amined yet in detail, the occurrence of three different muta-
tions in this helix suggests a requisite function in DNA binding.
Thus, these mutants strengthen the observation that dimeriza-
tion of E1 stabilizes origin DNA binding (6, 22).
Residues nonessential for DNA binding by E1 occur
throughout E1DBD and are rare in HR1 and HR3 regions.
The SSCP and temperature sensitivity assays detected yeast
clones expressing binding-functional mutations (Table 2).
Most of these DNA binding-functional mutations were non-
conservative, indicating that the side chains at these positions
make little if any contribution to E1DBD structure. The lack of
clustering of nonessential residues is also consistent with a
simple role, such as providing appropriate spacing to promote
proper orientation of essential residues in and near the critical
HR1 and HR3 regions. It should be noted that these residues
may be critical for other functions of the E1DBD, such as
interaction with the E2 protein or host cell replication pro-
teins, but this has not yet been determined. The only noncrit-
ical substitution which did occur in HR1 or HR3 was D185N in
mutant D185N/E258G/F278S. However, this is a structurally
conservative mutation and also can probably maintain the salt
bridge with R243, as discussed above, so it is not surprising that
this substitution was quite functional.
Unfortunately, since the binding-functional mutations that
we isolated are random in nature, interpretations that go be-
yond simple classification of these residues as nonessential for
sequence-specific DNA binding are difficult to make. Thus,
while quantification of reporter activity for our binding-func-
tional mutants is possible, definite conclusions about the rela-
tive importance of the individual residues cannot be made
without a more extensive site-directed mutational analysis at
each position. It has not escaped our attention that these
mutants could prove useful for studying other functions asso-
ciated with the E1DBD besides DNA binding. We currently
have found one example of a site-directed E1DBD mutation
which functions at wild-type levels in both DNA binding and
E2 interaction but still fails in DNA replication (unpublished
data). We are now screening our randomly generated binding-
functional mutants in DNA replication assays, and mutants
which bind origin DNA but fail to replicate it could define
functional defects at stages beyond origin recognition.
In summary, the results presented here strongly support the
roles of HR1 and HR3 as DNA contact elements for E1 pro-
tein. HR1 is part of an ordered loop structure, while HR3
forms the 4 helix, and these two elements are juxtaposed on
the surface of the E1DBD (10). Because of the greater toler-
ance for mutational changes in HR3 than in HR1, we propose
that HR3 may provide primarily nonspecific contacts with the
DNA, while HR1 may be the sequence specificity determinant.
SV40 T antigen has two structurally equivalent elements, A
and B2, which are also juxtaposed and which show limited
sequence similarity with the parallel E1 regions. A similar dual
element, loop plus helix, DNA binding motif also occurs in the
Epstein-Barr virus EBNA1 protein. In EBNA1 the helix is
positioned so that it can only contact the sugar-phosphate
backbone of the DNA, while the extended loop makes base
interactions (3), and we propose that the equivalent structures
in E1 perform the same general functions. Thus, all three
origin-binding proteins, E1, T antigen, and EBNA1, dock with
their palindromic binding sites using an apparently structurally
similar recognition mechanism.
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